Denali Therapeutics Inc. · NASDAQ:DNLI
Denali Therapeutics Inc. shareholders
As of Sep 30, 2026, 275 institutions reported holding Denali Therapeutics Inc., 95.1% of its shares. Largest: T. Rowe Price, Vanguard and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Denali Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| T. Rowe Price | 22.6M | 14.1% | +3.26M | Nov 16, 2026 |
| Vanguard | 14.8M | 9.2% | +822K | Nov 16, 2026 |
| BlackRock | 14.3M | 8.9% | +302K | Nov 13, 2026 |
| Baillie Gifford & Co | 11.1M | 6.9% | −840K | Nov 9, 2026 |
| Temasek Holdings (Private) Ltd | 7.01M | 4.4% | no change | Oct 28, 2026 |
| State Street | 6.68M | 4.2% | −367K | Nov 12, 2026 |
| UBS | 5.75M | 3.6% | −528K | Nov 16, 2026 |
| Fidelity | 4.53M | 2.8% | −2,715 | Nov 10, 2026 |
| Geode Capital | 4.04M | 2.5% | +65,478 | Nov 6, 2026 |
| Goldman Sachs | 3.75M | 2.3% | −401K | Nov 16, 2026 |